The PennZone

BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.

As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.

"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.

More on The PennZone

• On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
• Burkentine Builders Breaks Ground on Their 100,000-Square-Foot Warehouse in Shippensburg, PA
• NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
• Pine Creek Rail Trail Named Pennsylvania's 2026 Trail of the Year
• DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model

"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.

Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com

More on The PennZone

• CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
• Explosive $10 Billion Counter-Drone Market with AI-Powered Defense Ecosystem: ZenaTech, Inc. (N A S D A Q: ZENA)
• High-Value Execution Phase Begins: Bitcoin Bancorp Ignites Texas Rollout of Digital Asset ATM Network: Bitcoin Bancorp (Stock Symbol: BCBC) $BCBC
• Women's Wellness Conference Returns with a Powerful Call to Restoration
• UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

GripTract.com

ActuatedNeuroscience.com

TubeClear.com